newsfilter
← Latest News
PR Newswire·

MYND Life Sciences Announces DTC Eligibility

VANCOUVER, BC, Aug. 11, 2021 /PRNewswire/ - MYND Life Sciences Inc. (CSE:MYND) (OTC:MYNDF) ("MYND") is a drug research and development company focused on novel psychedelic drug development, diagnostic approaches and pharmaceuticals and vaccines is p